<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Technique of axillary lymph node dissection
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Technique of axillary lymph node dissection
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Technique of axillary lymph node dissection
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Julie Margenthaler, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Wenliang Chen, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 01, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H28306962">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Evaluation of the axilla provides information for treatment decisions in patients with invasive breast cancer. Axillary lymph node dissection (ALND) is the standard initial approach for breast cancer patients who are clinically node positive. Sentinel node biopsy is the standard initial approach for patients with early-stage breast cancer who are clinically node negative.
        </p>
        <p>
         The technique of ALND will be reviewed here. The approach to management of the regional lymph nodes in breast cancer, sentinel node biopsy indications and outcomes, sentinel node biopsy techniques, and effect of ALND on patient survival are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/813.html" rel="external">
          "Overview of management of the regional lymph nodes in breast cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/810.html" rel="external">
          "Overview of sentinel lymph node biopsy in breast cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/805.html" rel="external">
          "Sentinel lymph node biopsy in breast cancer: Techniques"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12293121">
         <span class="h1">
          INDICATIONS
         </span>
        </p>
        <p>
         An axillary lymph node dissection (ALND) is performed with the primary breast procedure (eg, lumpectomy or mastectomy) in patients who have:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Locally advanced (T3-T4; N0-2) or inflammatory breast cancer. (See
         <a class="medical medical_review" href="/z/d/html/810.html" rel="external">
          "Overview of sentinel lymph node biopsy in breast cancer", section on 'Contraindications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Needle-biopsy-proven metastatic disease in axillary lymph node(s), which are either clinically palpable or nonpalpable but abnormal by imaging (mostly ultrasound) criteria. (See
         <a class="medical medical_review" href="/z/d/html/810.html" rel="external">
          "Overview of sentinel lymph node biopsy in breast cancer", section on 'Preoperative axilla evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Even if neoadjuvant chemotherapy is administered to these patients, ALND should still be performed, regardless of the patient's response. (See
         <a class="medical medical_review" href="/z/d/html/810.html" rel="external">
          "Overview of sentinel lymph node biopsy in breast cancer", section on 'Neoadjuvant chemotherapy'
         </a>
         .)
        </p>
        <p>
         For all other patients who are diagnosed with breast cancer, a sentinel lymph node biopsy (SLNB) is performed in lieu of ALND before or with the primary breast procedure (eg, lumpectomy or mastectomy). (See
         <a class="medical medical_review" href="/z/d/html/810.html" rel="external">
          "Overview of sentinel lymph node biopsy in breast cancer"
         </a>
         .)
        </p>
        <p>
         Following SLNB, a completion ALND (cALND) is performed for:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Three or more positive lymph nodes found in patients with small (≤5 cm) tumors (T1 or T2). (See
         <a class="medical medical_review" href="/z/d/html/810.html" rel="external">
          "Overview of sentinel lymph node biopsy in breast cancer", section on 'Three or more sentinel node metastases'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Any number of positive lymph node(s) found in patients with large (&gt;5 cm) tumors (T3). (See
         <a class="medical medical_review" href="/z/d/html/810.html" rel="external">
          "Overview of sentinel lymph node biopsy in breast cancer", section on 'Sentinel node metastasis with large tumor'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Any number of positive lymph node(s) found with extranodal extension (ENE) of tumor cells. (See
         <a class="medical medical_review" href="/z/d/html/810.html" rel="external">
          "Overview of sentinel lymph node biopsy in breast cancer", section on 'Sentinel node metastasis with extranodal extension'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Any number of positive lymph node(s) found in patients who will not receive whole breast irradiation because they undergo a mastectomy, receive partial breast irradiation, or refuse breast irradiation.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8369105">
         <span class="h1">
          SURGICAL ANATOMY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The surgeon must understand the complex anatomy of the axilla in order to preserve maximum muscular function and sensation (
         <a class="graphic graphic_figure graphicRef58037" href="/z/d/graphic/58037.html" rel="external">
          figure 1
         </a>
         and
         <a class="graphic graphic_figure graphicRef69782" href="/z/d/graphic/69782.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid1">
          1-3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8370030">
         <span class="h2">
          Borders of the axilla
         </span>
         <span class="headingEndMark">
          —
         </span>
         The boundaries of the axillary lymph node dissection (ALND) are the axillary vein superiorly, the serratus anterior muscle medially, and the latissimus dorsi muscle laterally (
         <a class="graphic graphic_figure graphicRef62255" href="/z/d/graphic/62255.html" rel="external">
          figure 3
         </a>
         ). From the anatomic perspective, the axillary space is actually a pyramidal compartment with an apex, base, and four walls.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The apex of the axilla is the costoclavicular ligament.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The base of the axilla is comprised of skin and axillary fascia.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The anterior boundary of the axilla is the pectoralis major and pectoralis minor and subclavius muscles, enclosed in the clavipectoral fascia.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The posterior boundary of the axilla is the subscapularis, teres minor, and latissimus dorsi muscles.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The lateral wall of the axilla is the narrow space at the bicipital groove on the humerus between the insertions of the muscles of the anterior and posterior walls.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The medial border of the axilla is the ribs and intercostal muscles covered with the serratus anterior muscle.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5542921">
         <span class="h2">
          Contents of the axilla
         </span>
         <span class="headingEndMark">
          —
         </span>
         The axilla contains the blood vessels, lymphatic trunks, and nerves to the arm. The dissection should be inferior to the axillary vein; thus, the axillary artery and brachial plexus (
         <a class="graphic graphic_figure graphicRef50576" href="/z/d/graphic/50576.html" rel="external">
          figure 4
         </a>
         ) are superior to the surgical field.
        </p>
        <p class="headingAnchor" id="H8370037">
         <span class="h3">
          Motor nerves
         </span>
         <span class="headingEndMark">
          —
         </span>
         The major motor nerves of the axilla encountered during axillary dissection include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The long thoracic nerve ("nerve of Bell") runs parallel to the chest wall and innervates the serratus anterior muscle. If this nerve is injured, the patient will have a protruding "winged" scapula deformity.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The thoracodorsal nerve marks the deep aspect of the axillary space and innervates the latissimus dorsi muscle. Injury to this nerve partially denervates the latissimus dorsi and may lead to mild weakness of internal rotation and shoulder adduction. Usually, the deficit is well compensated by the remaining intact shoulder musculature.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The medial and lateral pectoral nerves innervate the pectoralis minor and major muscles. Injury to these nerves leads to denervation atrophy and shortening of the pectoral muscles with limitation of shoulder mobility and compromise of the cosmetic result.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8370044">
         <span class="h3">
          Sensory nerves
         </span>
         <span class="headingEndMark">
          —
         </span>
         The intercostobrachial nerves are sensory nerves that traverse the axilla to supply the skin on the medial and posterior arm, axilla, and posterior axillary line. The intercostobrachial nerves exit the fascia of the chest wall at the second and third intercostal spaces. The highest intercostal brachial nerves supply sensation to the upper medial arm, and the patient will have diminished sensation or hyperesthesias if these nerves are injured. The lower intercostal nerves supply skin sensation to the axilla and are rarely saved since they course through the specimen.
        </p>
        <p class="headingAnchor" id="H8370051">
         <span class="h3">
          Lymph nodes
         </span>
         <span class="headingEndMark">
          —
         </span>
         The axillary lymph nodes are divided into three levels based upon their relationship to the pectoralis minor muscle (
         <a class="graphic graphic_figure graphicRef74746" href="/z/d/graphic/74746.html" rel="external">
          figure 5
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Level I: Inferior and lateral to the pectoralis minor muscle.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Level II: Posterior to the pectoralis minor and below the axillary vein.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Level III (infraclavicular): Medial to the pectoralis minor and against the chest wall; involvement of these nodes alters nodal staging classification due to their poor prognostic significance. Level III lymph node involvement automatically confers a pN3 status (
         <a class="graphic graphic_table graphicRef65393" href="/z/d/graphic/65393.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid4">
          4
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/800.html" rel="external">
          "Tumor, node, metastasis (TNM) staging classification for breast cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H815960">
         <span class="h3">
          Blood vessels
         </span>
         <span class="headingEndMark">
          —
         </span>
         The axillary artery and vein are enclosed within the axillary sheath with the brachial plexus (
         <a class="graphic graphic_figure graphicRef61941" href="/z/d/graphic/61941.html" rel="external">
          figure 6
         </a>
         ). The thoracodorsal artery and vein travel with the thoracodorsal nerve and should be preserved (
         <a class="graphic graphic_figure graphicRef78501" href="/z/d/graphic/78501.html" rel="external">
          figure 7
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H815739">
         <span class="h1">
          PREOPERATIVE PREPARATION
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Operating room safety
         </strong>
         – Operating room safety, including obtaining informed consent and site marking, is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/15077.html" rel="external">
          "Patient safety in the operating room"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anesthesia
         </strong>
         – An axillary lymph node dissection (ALND) is performed under general anesthesia. The patient should
         <strong>
          not
         </strong>
         be paralyzed, so that testing of the large motor nerves during dissection is possible.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antibiotics
         </strong>
         –
         <strong>
         </strong>
         A preoperative antibiotic, such as
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         , should be administered after arriving in the operating room and before the incision is made [
         <a href="#rid5">
          5-7
         </a>
         ]. The efficacy of antibiotic prophylaxis decreases if administered more than one hour before surgery (
         <a class="graphic graphic_table graphicRef79097" href="/z/d/graphic/79097.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid8">
          8-10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A meta-analysis of the randomized controlled trials of preoperative antibiotics versus placebo in patients undergoing breast surgery found that the use of preoperative antibiotics was associated with a significant reduction in infection (relative risk 0.60; 95% CI 0.45-0.81) [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Deep venous thrombosis prophylaxis
         </strong>
         –
         <strong>
         </strong>
         For patients undergoing general anesthesia, primary prophylaxis for prevention of deep venous thrombosis, such as sequential compression devices, should be employed. (See
         <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">
          "Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H28307036">
         <span class="h1">
          SURGICAL TECHNIQUE
         </span>
         <span class="headingEndMark">
          —
         </span>
         An axillary lymph node dissection (ALND) is usually performed through a small incision, and confirmation of the anatomic landmarks is crucial for avoiding injuries with functional consequences [
         <a href="#rid1">
          1-3
         </a>
         ]. (See
         <a class="local">
          'Surgical anatomy'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H816049">
         <span class="h2">
          Positioning
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patient positioning should allow maximum exposure of the axilla. The patient is positioned supine with their arms extended on arm boards at ≤90 degrees abduction from the chest wall. Arm positioning with &gt;90 degrees of abduction from the chest wall increases the potential for stretching the brachial plexus and should be avoided. It is important to position the arm while the patient is awake to make sure the arm is not abducted beyond what is comfortable for the patient, especially if there are preexisting problems with shoulder mobility.
        </p>
        <p>
         The ipsilateral arm can be included in the prepped field at the discretion of the surgeon, allowing the arm to be mobilized during the procedure. The lateral chest wall should be positioned along the edge of the operating table. After the patient is securely belted, the table can be tilted with the operative side up to allow optimal visualization of the axilla.
        </p>
        <p class="headingAnchor" id="H816057">
         <span class="h2">
          Incision
         </span>
         <span class="headingEndMark">
          —
         </span>
         An
         <strong>
         </strong>
         ALND may be performed within the context of a modified radical mastectomy for patients requiring complete removal of the breast, in combination with a partial mastectomy for breast conservation, or as a separate procedure. (See
         <a class="medical medical_review" href="/z/d/html/807.html" rel="external">
          "Breast-conserving therapy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14981.html" rel="external">
          "Mastectomy"
         </a>
         .)
        </p>
        <p>
         The incision will vary depending upon the breast surgery being performed:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients undergoing an ALND alone or concurrently with partial mastectomy, a curvilinear incision is made approximately 1 to 2 cm below the edge of the axillary hair line following the natural skin folds (Langer's lines), extending from the anterior to the posterior axillary fold (
         <a class="graphic graphic_figure graphicRef52834" href="/z/d/graphic/52834.html" rel="external">
          figure 8
         </a>
         ). A better cosmetic result is obtained if the incision does not cross the anterior or posterior axillary folds.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients undergoing standard modified radical mastectomy without reconstruction, the ALND can be performed through the mastectomy incision once the breast has been removed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients undergoing a skin-sparing modified radical mastectomy with immediate reconstruction, the skin opening can be positioned over the axilla once the breast is removed to allow for the ALND. A small radial skin incision can be extended laterally to facilitate this approach. Alternatively, a separate incision in the axilla can be used when it is not feasible to reach the axilla through the breast skin opening.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H816102">
         <span class="h2">
          Critical steps of the dissection
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition of pectoralis muscles
         </strong>
         – The lateral edge of the pectoralis major muscle is retracted medially to expose the pectoralis minor muscle and allow interpectoral dissection of Rotter's lymph nodes. The medial pectoral neurovascular bundle, which innervates the pectoralis major and minor muscles, should be preserved during the dissection. The neurovascular bundle passes through the pectoralis minor muscle in 60 percent of patients and passes laterally around the pectoralis minor muscle in 40 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Identification of latissimus dorsi
         </strong>
         – The anterior surface of the latissimus dorsi muscle is the lateral border of the axillary dissection (
         <a class="graphic graphic_figure graphicRef64682" href="/z/d/graphic/64682.html" rel="external">
          figure 9
         </a>
         ). Dissection along the latissimus dorsi border is extended inferiorly until the muscle begins to pull toward the chest wall and superiorly to the tendon of insertion.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clavipectoral fascia
         </strong>
         –
         <strong>
         </strong>
         The clavipectoral fascia is divided at the level of the inferior axillary sheath to expose the underlying fat pad and axillary lymph nodes within the fat.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Axillary vein
         </strong>
         – Dissection is carried posteriorly until the axillary vein is visualized, with care not to open the axillary sheath and strip or skeletonize the vein unless there is extensive nodal disease, because this increases the risk of injury to the vessels and lymphatics, which can increase the risk of lymphedema [
         <a href="#rid2">
          2
         </a>
         ]. The axillary vein often bifurcates or trifurcates within the axillary space. Thus, transverse venous structures high in the axilla should
         <strong>
          never
         </strong>
         be ligated, even when they appear smaller than that expected for an axillary vein.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mobilization of the axillary fat pad
         </strong>
         – The fatty tissue and nodes are dissected off the chest wall and the inferior surface of the axillary vein.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Identification of intercostobrachial nerves
         </strong>
         –
         <strong>
         </strong>
         The sensory intercostobrachial nerves are encountered during the lateral dissection along the latissimus dorsi. It is difficult to spare branches that are located far inferior to the axillary vein, but this can be accomplished with careful dissection. By sharp dissection, the adventitial tissues can be incised along the nerve so that the nerve can be retracted anteriorly away from the underlying axillary fat pad and contents. If the intercostobrachial nerve branches cannot be spared, ligation should be performed sharply to avoid electrocautery conduction injury.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Identification of motor nerves
         </strong>
         – The positions of the long thoracic nerve and thoracodorsal neurovascular bundle can vary slightly from patient to patient. The best approach is to preserve all neural and vascular structures in unexpected positions, until the full axillary anatomy can be determined and before anything critical is sacrificed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The long thoracic nerve is identified by blunt dissection just below the medial aspect of the axillary vein and just lateral to the chest wall. One can often feel the nerve prior to visualizing it by palpating the tissues along the chest wall (
         <a class="graphic graphic_figure graphicRef53451" href="/z/d/graphic/53451.html" rel="external">
          figure 10
         </a>
         ). Once the nerve is identified, the plane is extended inferiorly for the length of the axillary field. It is important to try to keep the long thoracic nerve against the chest wall to reduce the likelihood of injury. The fascial layer on the serratus anterior that holds the long thoracic nerve in place should
         <strong>
          not
         </strong>
         be breached, to avoid injury to the nerve.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The thoracodorsal neurovascular bundle can be identified by dissecting in the mid-axilla just inferior to the axillary vein (
         <a class="graphic graphic_figure graphicRef78501" href="/z/d/graphic/78501.html" rel="external">
          figure 7
         </a>
         ). There is often a large superficial venous tributary arising from the axillary vein, called the thoracoepigastric vein, which is often just anterior to the position of the thoracodorsal neurovascular bundle. This superficial vein should not be transected until the neurovascular bundle is confirmed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Extent of dissection
         </strong>
         –
         <strong>
         </strong>
         The
         <strong>
         </strong>
         extent of dissection is defined by anatomic location (
         <a class="graphic graphic_figure graphicRef57770" href="/z/d/graphic/57770.html" rel="external">
          figure 11
         </a>
         ). An accurate determination of the nodal level of a resected specimen can only be made if the specimen is marked by the surgeon or separated into levels before it is evaluated by the pathologist. (See
         <a class="local">
          'Surgical anatomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The extent of dissection is a tradeoff between the greater morbidity of a more extensive ALND and the possibility of leaving residual untreated axillary disease. In general, a level I and II anatomic ALND is the preferred procedure for axillary assessment [
         <a href="#rid12">
          12
         </a>
         ]. The typical level I/II dissection should yield ≥10 axillary lymph nodes, although the range is highly variable. The risk of axillary recurrence is inversely related to the number of removed axillary lymph nodes in a formal ALND. The axillary failure rates increase when fewer than five lymph nodes (LNs) are removed (5 to 21 percent) as compared with when more than five LNs are removed (3 to 5 percent) [
         <a href="#rid13">
          13-15
         </a>
         ]. (See
         <a class="local">
          'Lymph nodes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Routine removal of level III nodes is unnecessary for staging but should be carried out to maximize local control if grossly positive axillary lymph nodes are identified intraoperatively. Level III lymph node dissection significantly increases the morbidity of the ALND. This level is not generally formally dissected; clinically suspicious level III nodes are separately resected and labeled as such for the pathologist. The reported incidence of skip metastases in the level III nodes with uninvolved level I nodes ranges from 0.2 to 3.1 percent [
         <a href="#rid16">
          16-21
         </a>
         ]. These numbers correlate well with locoregional recurrence rates following a level I and II ALND in women undergoing breast-conserving surgery (3 percent or less) [
         <a href="#rid13">
          13,22-24
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/807.html" rel="external">
          "Breast-conserving therapy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Completion of dissection
         </strong>
         – Once the long thoracic and thoracodorsal nerves have been identified, the axillary contents can be removed from the defined boundaries. Blunt dissection is used to define the tissue planes between the axillary fat pad and contents and the underlying structures, progressing from superior to inferior in the operative field (
         <a class="graphic graphic_figure graphicRef63143" href="/z/d/graphic/63143.html" rel="external">
          figure 12
         </a>
         ). Palpation of level III nodes can then be performed by running the ventral surface of the index finger behind the pectoralis minor muscle and toward the infraclavicular space. If clinically suspicious nodes are palpated, they can be separately resected by retracting the pectoralis minor muscle for exposure.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H816085">
         <span class="h2">
          Drains
         </span>
         <span class="headingEndMark">
          —
         </span>
         Before closure, some surgeons place a closed suction drain in the axillary space through a separate stab wound in the low axilla above the bra line. Other surgeons prefer not to place a drain; they aspirate any seroma that develops in the postoperative period, which is more
         <strong>
         </strong>
         comfortable for the patient and allows discharge after surgery without a hospital stay or cumbersome drain care [
         <a href="#rid25">
          25
         </a>
         ]. Meta-analyses of available randomized trials have demonstrated that axillary drains decrease seroma formation and the volume and frequency of postoperative seroma aspiration; however, they extend hospital stay and do not affect the incidence of wound infection [
         <a href="#rid26">
          26-28
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4692244">
         <span class="h2">
          Axillary reverse mapping
         </span>
         <span class="headingEndMark">
          —
         </span>
         Axillary reverse mapping (ARM) is an experimental technique being investigated as a method of preserving the upper extremity lymphatics during ALND in an attempt to reduce the risk of postoperative lymphedema [
         <a href="#rid29">
          29-31
         </a>
         ]. Blue dye is injected in the upper inner ipsilateral arm, and blue lymphatics and nodes are avoided during ALND. In two studies of 23 patients each, metastases were present in the nodes related to ARM sampling in 14 and 60 percent of patients, respectively [
         <a href="#rid29">
          29,31,32
         </a>
         ]. Thus, further studies are needed to determine the long-term oncologic outcomes of this novel technique, which should not be used outside of a clinical trial.
        </p>
        <p class="headingAnchor" id="H28307073">
         <span class="h1">
          POSTOPERATIVE CARE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pain control is achieved with
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         or a short course of narcotics. (See
         <a class="medical medical_review" href="/z/d/html/130312.html" rel="external">
          "Approach to the management of acute pain in adults"
         </a>
         .)
        </p>
        <p>
         If a drain was used, the patient is instructed on the care of the axillary drain and asked to keep a daily log of the drainage volume. The drain can be removed when the output is 30 mL or less a day. Activity restrictions include avoidance of submersion of the incision in water and avoidance of driving, strenuous activity, or heavy lifting while the drain is in place. After drain removal, patients are encouraged to gradually increase their level of activity and range of motion.
        </p>
        <p>
         If a drain was not used, the patient should be evaluated for seroma formation a week after surgery. If the seroma is large or symptomatic, it should be aspirated. A small seroma will usually respond to conservative care with rest, arm elevation, and icing of the axilla.
        </p>
        <p>
         Simple range-of-motion exercises will enable most patients to resume full activity. Some patients may require physical therapy to regain full range of motion. Patients should receive instruction in the prevention and recognition of lymphedema. (See
         <a class="medical medical_review" href="/z/d/html/738.html" rel="external">
          "Clinical staging and conservative management of peripheral lymphedema"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/882.html" rel="external">
          "Patient education: Lymphedema after cancer surgery (Beyond the Basics)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28307087">
         <span class="h1">
          COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The anatomic disruption caused by axillary lymph node dissection (ALND) may result in lymphedema, nerve injury, and shoulder dysfunction, which compromise functionality and quality of life.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infection
         </strong>
         – The incidence of postoperative wound infection following axillary dissection varies from 3 to 15 percent in the literature, though it is difficult to assess the contribution of ALND in the setting of a combined breast surgical procedure [
         <a href="#rid33">
          33-36
         </a>
         ]. The most common organisms are usually gram positive (streptococcal or staphylococcal species) and will respond to treatment with appropriate oral antibiotics. If there is an underlying seroma, it should be aspirated and cultured to direct antibiotic treatment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hematoma
         </strong>
         – The reported incidence of postoperative hematoma has varied from 2 to 10 percent [
         <a href="#rid33">
          33,34,37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Seroma
         </strong>
         – The normal lymphatic drainage of the breast to the axilla can lead to seroma formation after axillary dissection [
         <a href="#rid37">
          37
         </a>
         ]. Seromas can be diminished with the use of drains or managed via percutaneous aspiration [
         <a href="#rid38">
          38
         </a>
         ]. (See
         <a class="local">
          'Drains'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Arm morbidity
         </strong>
         – Lymphedema of the arm is a potential and serious complication of ALND. The rate varies substantially with the level of dissection and whether postoperative radiation therapy is used.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a meta-analysis of 98 prospective or retrospective cohort studies and randomized control trials that included patients undergoing an axillary procedure for breast cancer, patients undergoing a
         <strong>
          radical mastectomy
         </strong>
         were significantly more likely to develop arm lymphedema compared with patients undergoing a less aggressive mastectomy procedure (risk ratio [RR] 3.28, 95% CI 2.35-4.59) [
         <a href="#rid39">
          39
         </a>
         ]. Additional pertinent risks for lymphedema included:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patients undergoing a
         <strong>
          mastectomy
         </strong>
         were significantly more likely to develop arm lymphedema compared with patients undergoing a partial mastectomy (RR 1.42, 95% CI 1.15-1.76).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patients undergoing an
         <strong>
          axillary lymph node dissection
         </strong>
         were significantly more likely to develop lymphedema compared with patients undergoing a sentinel lymph node dissection (RR 3.07, 95% CI 2.20-4.29).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patients undergoing any
         <strong>
          radiation treatments to the axilla
         </strong>
         had a higher rate of lymphedema compared with no axillary radiation treatments (RR 2.97, 95% CI 2.06-4.28).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patients with
         <strong>
          positive axillary lymph nodes
         </strong>
         also had a higher rate of lymphedema compared with patients who were axillary node negative (RR 1.54, 95% CI 1.32-1.80).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Shoulder stiffness and numbness and paresthesias in the upper arm are common complaints following an ALND. Although these symptoms do not usually interfere with daily living, they may reduce the quality of life [
         <a href="#rid40">
          40-44
         </a>
         ]. In one series, 42 percent of women had subjective or objective arm impairment (eg, pain, reduced grip strength) one year after an ALND [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Prevention, clinical manifestations and diagnosis, and management of lymphedema are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/755.html" rel="external">
          "Clinical features and diagnosis of peripheral lymphedema"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/738.html" rel="external">
          "Clinical staging and conservative management of peripheral lymphedema"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/882.html" rel="external">
          "Patient education: Lymphedema after cancer surgery (Beyond the Basics)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nerve injury
         </strong>
         – The risk of major motor nerve injury following an ALND is &lt;1 percent. Injury to the
         <strong>
         </strong>
         long thoracic nerve results in a winged scapula. Injury to the thoracodorsal nerve weakens shoulder adduction and internal rotation. Injury to the medial pectoral nerve may lead to atrophy of the lateral aspect of the pectoralis major muscle, which may impact the overall cosmetic result. Transection of the intercostobrachial nerve results in numbness and paresthesias on the inner upper arm. (See
         <a class="local">
          'Motor nerves'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/2827.html" rel="external">
          "Physical rehabilitation for cancer survivors"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3010781113">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/119871.html" rel="external">
          "Society guideline links: Breast surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28307101">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications
         </strong>
         – Evaluation of the axilla provides information for treatment decisions in patients with invasive breast cancer. Axillary lymph node dissection (ALND) remains the standard initial approach for breast cancer patients who have locally advanced or inflammatory breast cancer and needle-biopsy-proven metastatic disease in axillary lymph node(s). Sentinel lymph node biopsy (SLNB) is the standard initial approach for all other patients with early-stage breast cancer who are clinically node negative. (See
         <a class="local">
          'Indications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Following SLNB, a completion ALND (cALND) is indicated when there are three or more positive lymph nodes found in patients with small (≤5 cm) tumors (T1 or T2), any number of positive lymph nodes found in patients with large (&gt;5 cm) tumors (T3) or extranodal extension of tumor cells, and any number of positive lymph nodes found in those who will not undergo whole breast irradiation. (See
         <a class="local">
          'Indications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anatomy
         </strong>
         – The surgeon must understand the complex anatomy of the axilla in order to preserve maximum muscular function and sensation. The level of the ALND is defined by anatomic location. Axillary lymph nodes are divided into three levels based upon their relationship to the pectoralis minor muscle. (See
         <a class="local">
          'Surgical anatomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Surgical technique
         </strong>
         – An ALND is usually performed through a small incision, and confirmation of the anatomic landmarks is crucial for avoiding injuries with functional consequences. (See
         <a class="local">
          'Surgical technique'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complications
         </strong>
         – The anatomic disruption caused by the ALND may result in lymphedema, nerve injury, and shoulder dysfunction, which compromise functionality and quality of life. (See
         <a class="local">
          'Complications'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Anson BJ, McVay CB. Thoracic walls: Breast or mammary region. In: Surgical Anatomy, 6th ed, Anson BJ, McVay CB (Eds), Saunders, 1984. p.357.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petrek JA, Blackwood MM. Axillary dissection: current practice and technique. Curr Probl Surg 1995; 32:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ung O, Tan M, Chua B, Barraclough B. Complete axillary dissection: a technique that still has relevance in contemporary management of breast cancer. ANZ J Surg 2006; 76:518.
          </a>
         </li>
         <li class="breakAll">
          AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 6th ed, Greene FL, Page DL, Fleming ID, et al (Eds), Springer-Verlag, 2002. p.223.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leaper DJ, Melling AG. Antibiotic prophylaxis in clean surgery: clean non-implant wounds. J Chemother 2001; 13 Spec No 1:96.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gagliardi AR, Fenech D, Eskicioglu C, et al. Factors influencing antibiotic prophylaxis for surgical site infection prevention in general surgery: a review of the literature. Can J Surg 2009; 52:481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Throckmorton AD, Boughey JC, Boostrom SY, et al. Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients. Ann Surg Oncol 2009; 16:2464.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fry DE. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braxton CC, Gerstenberger PA, Cox GG. Improving antibiotic stewardship: order set implementation to improve prophylactic antimicrobial prescribing in the outpatient surgical setting. J Ambul Care Manage 2010; 33:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tejirian T, DiFronzo LA, Haigh PI. Antibiotic prophylaxis for preventing wound infection after breast surgery: a systematic review and metaanalysis. J Am Coll Surg 2006; 203:729.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           NIH consensus conference. Treatment of early-stage breast cancer. JAMA 1991; 265:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fowble B, Solin LJ, Schultz DJ, Goodman RL. Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys 1989; 17:703.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graversen HP, Blichert-Toft M, Andersen JA, Zedeler K. Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla. Eur J Surg Oncol 1988; 14:407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981; 152:765.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veronesi U, Rilke F, Luini A, et al. Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. Cancer 1987; 59:682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pigott J, Nichols R, Maddox WA, Balch CM. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures. Surg Gynecol Obstet 1984; 158:255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections. Ann Surg 1983; 197:276.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Danforth DN Jr, Findlay PA, McDonald HD, et al. Complete axillary lymph node dissection for stage I-II carcinoma of the breast. J Clin Oncol 1986; 4:655.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chevinsky AH, Ferrara J, James AG, et al. Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast. Surgery 1990; 108:612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boova RS, Bonanni R, Rosato FE. Patterns of axillary nodal involvement in breast cancer. Predictability of level one dissection. Ann Surg 1982; 196:642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer 1992; 28A:1415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Halverson KJ, Taylor ME, Perez CA, et al. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 1993; 26:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Recht A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991; 9:988.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jeffrey SS, Goodson WH 3rd, Ikeda DM, et al. Axillary lymphadenectomy for breast cancer without axillary drainage. Arch Surg 1995; 130:909.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Droeser RA, Frey DM, Oertli D, et al. Volume-controlled vs no/short-term drainage after axillary lymph node dissection in breast cancer surgery: a meta-analysis. Breast 2009; 18:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           He XD, Guo ZH, Tian JH, et al. Whether drainage should be used after surgery for breast cancer? A systematic review of randomized controlled trials. Med Oncol 2011; 28 Suppl 1:S22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomson DR, Sadideen H, Furniss D. Wound drainage after axillary dissection for carcinoma of the breast. Cochrane Database Syst Rev 2013; :CD006823.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nos C, Kaufmann G, Clough KB, et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol 2008; 15:2550.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thompson M, Korourian S, Henry-Tillman R, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol 2007; 14:1890.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bedrosian I, Babiera GV, Mittendorf EA, et al. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 2010; 116:2543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tausch C, Baege A, Dietrich D, et al. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? Eur J Surg Oncol 2013; 39:880.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer. Ann Surg Oncol 2008; 15:1996.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Langer I, Guller U, Berclaz G, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 2007; 245:452.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006; 98:599.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 2007; 25:3657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vitug AF, Newman LA. Complications in breast surgery. Surg Clin North Am 2007; 87:431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pogson CJ, Adwani A, Ebbs SR. Seroma following breast cancer surgery. Eur J Surg Oncol 2003; 29:711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsai RJ, Dennis LK, Lynch CF, et al. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 2009; 16:1959.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kwan W, Jackson J, Weir LM, et al. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 2002; 20:4242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ivens D, Hoe AL, Podd TJ, et al. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992; 66:136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993; 11:1536.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hladiuk M, Huchcroft S, Temple W, Schnurr BE. Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol 1992; 50:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keramopoulos A, Tsionou C, Minaretzis D, et al. Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. Oncology 1993; 50:445.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 14984 Version 28.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Anson BJ, McVay CB. Thoracic walls: Breast or mammary region. In: Surgical Anatomy, 6th ed, Anson BJ, McVay CB (Eds), Saunders, 1984. p.357.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7705102" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Axillary dissection: current practice and technique.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16768781" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Complete axillary dissection: a technique that still has relevance in contemporary management of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16768781" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Complete axillary dissection: a technique that still has relevance in contemporary management of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11936388" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Antibiotic prophylaxis in clean surgery: clean non-implant wounds.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20011184" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Factors influencing antibiotic prophylaxis for surgical site infection prevention in general surgery: a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19506959" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19216670" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15227616" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20228636" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Improving antibiotic stewardship: order set implementation to improve prophylactic antimicrobial prescribing in the outpatient surgical setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17084336" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Antibiotic prophylaxis for preventing wound infection after breast surgery: a systematic review and metaanalysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1984541" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : NIH consensus conference. Treatment of early-stage breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2550398" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3181444" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7244951" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3802027" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Distribution of axillary node metastases by level of invasion. An analysis of 539 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6701738" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6830335" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3701387" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2218870" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7149815" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Patterns of axillary nodal involvement in breast cancer. Predictability of level one dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1515262" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8330987" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2033433" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7632155" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Axillary lymphadenectomy for breast cancer without axillary drainage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19289285" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Volume-controlled vs no/short-term drainage after axillary lymph node dissection in breast cancer surgery: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20827578" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Whether drainage should be used after surgery for breast cancer? A systematic review of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24158902" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Wound drainage after axillary dissection for carcinoma of the breast.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18618185" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17479341" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20336790" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23735162" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18415650" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17435553" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16670385" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17485711" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17498536" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Complications in breast surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14602488" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Seroma following breast cancer surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19365624" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12377968" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1637663" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Assessment of morbidity from complete axillary dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8336192" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Impact of axillary lymph node dissection on the therapy of breast cancer patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1573894" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8233285" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
